editor
xlink
lymphoprolif
diseas
first
describ
rare
primari
immunodefici
pid
caus
mutat
gene
gene
encod
slamassoci
protein
sap
key
regul
immun
function
nk
nkt
cell
defect
protein
may
lead
cellular
humor
immun
defect
character
patient
clinic
manifest
vari
includ
hemophagocyt
lymphohistiocytosi
hlh
lymphoma
dysgammaglobulinemia
patient
experi
wide
rang
phenotyp
associ
immun
dysregul
even
independ
epsteinbarr
viru
ebv
infect
although
histor
associ
ebv
infect
recent
studi
show
patient
evid
previou
ebv
infect
patient
often
diagnos
base
posit
famili
histori
alon
clear
genotypephenotyp
correl
identifi
report
three
sibl
nonconsanguin
famili
yemeni
origin
hemizyg
delet
exon
gene
manifest
differ
phenotyp
differ
age
tabl
patient
one
well
month
age
develop
bilater
bronchopneumonia
pleural
effus
requir
hospit
admiss
investig
confirm
sever
hypogammaglobulinemia
mark
lymphocytosi
subsequ
hemizyg
delet
exon
gene
commenc
immunoglobulin
replac
therapi
monitor
regularli
lung
function
chest
imag
show
chronic
chang
donor
search
hematopoiet
stem
cell
transplant
hsct
identifi
best
avail
donor
haploident
donor
therefor
hsct
undertaken
earli
age
first
develop
ebv
viremia
six
year
old
receiv
three
cours
rituximab
next
five
year
deplet
b
cell
ebv
viremia
persist
analysi
confirm
presenc
ebv
nk
cell
recent
develop
fever
weight
loss
increas
cough
investig
reveal
autoimmun
hemolyt
anemia
aiha
requir
rituximab
highdos
intraven
immunoglobulin
ivig
alongsid
lower
lobe
lung
collaps
associ
haemophilu
influenza
treat
prolong
cours
antibiot
time
b
cell
return
deplet
upon
rituximab
administr
remain
immunoglobulin
therapi
prophylact
antibiot
await
hsct
patient
two
diagnos
birth
base
posit
famili
histori
remain
well
three
year
age
develop
intermitt
abdomin
pain
associ
fever
night
sweat
diarrhea
constip
investig
confirm
rais
ldh
anemia
neg
ebv
pcr
ebv
neg
capsul
summari
present
mani
differ
way
genotypephenotyp
correl
therefor
close
monitor
extrem
import
especi
famili
histori
lymphoma
case
xlp
patient
abdomin
ct
scan
demonstr
mark
thicken
distal
ileum
patholog
mesenter
right
iliac
fossa
enlarg
lymph
node
biopsi
consist
nonhodgkin
lymphoma
receiv
two
cycl
rgrab
cyclophosphamid
doxorubicin
vincristin
prednisolon
methotrex
folin
acid
etoposid
tioguanin
cytarabin
intrathec
methotrex
rituximab
chemotherapi
proceed
mismatch
unrel
cord
blood
transplant
tabl
success
engraft
donor
engraft
last
followup
two
year
posthsct
develop
grade
ii
gut
skin
graft
versu
host
diseas
gvhd
complet
resolut
also
develop
aiha
posthsct
requir
steroid
rituximab
highdos
ivig
cyclosporin
stop
follow
develop
posterior
revers
encephalopathi
syndrom
pre
current
fit
well
diagnosi
confirm
patient
three
four
month
age
thrive
develop
normal
month
age
present
gener
seizur
brain
ct
mri
scan
show
multipl
area
signal
abnorm
cerebr
hemispher
intern
capsul
cerebellum
hydrocephalu
hemorrhag
fig
requir
picu
admiss
ventil
control
seizur
lumbar
punctur
show
rais
protein
csf
cell
present
evid
hemophagocytosi
bone
marrow
aspir
trephin
never
develop
system
featur
hlh
ferritin
modestli
rais
peak
around
triglycerid
mmoll
solubl
pgml
evid
ebv
infect
commenc
hlh
protocol
howev
receiv
two
dose
etoposid
due
develop
mucos
repeat
brain
mri
show
progress
focal
lesion
evolv
brainstem
herniat
extern
ventricular
devic
insert
decompress
ventricl
reliev
edema
brain
biopsi
confirm
lymphocyt
infiltr
featur
immun
dysregul
definit
hemophagocytosi
histopatholog
salvag
therapi
progress
cn
hlh
treat
alemtuzumab
mgkg
total
led
modest
cn
improv
develop
right
lower
zone
consolid
impair
ventil
nasopharyng
secret
posit
respiratori
syncyti
viru
treatment
zanamivir
ribavirin
initi
lung
biopsi
perform
pretranspl
show
scar
signific
fibrosi
macrophag
infiltr
neg
cultur
pcr
underw
tcr
alphabeta
hsct
mmud
detail
tabl
donor
engraft
whole
blood
howev
develop
numer
complic
posttranspl
includ
thrombot
microangiopathi
tma
grade
iii
skin
gvhd
mycobacterium
abscessu
stenotrophomona
lung
infect
widespread
skin
breakdown
sever
month
abdomin
distent
discomfort
note
rais
lactat
abdomin
ct
scan
demonstr
fatti
infiltr
grossli
distend
liver
rapidli
develop
liver
failur
progress
multiorgan
failur
sadli
die
nine
month
posttranspl
disord
sever
immun
dysregul
hlh
lymphoma
humor
abnorm
among
spectrum
manifest
associ
increas
suscept
sever
ebv
infect
howev
patient
ebv
neg
diagnosi
may
alreadi
display
clinic
phenotyp
appear
signific
differ
mortal
seen
ebvposit
ebvneg
patient
famili
illustr
xlp
manag
conserv
physician
need
maintain
high
index
suspicion
complic
immun
dysregul
may
present
indol
isol
organ
present
consid
high
morbid
mortal
rate
strongli
recommend
genet
screen
counsel
carri
famili
histori
howev
patient
diagnos
birth
due
posit
famili
histori
still
carri
signific
risk
mortal
despit
monitor
demonstr
highlight
sever
disord
consid
lack
genotypephenotyp
correl
unpredict
cours
close
monitor
remain
critic
allow
prevent
infect
organ
damag
bronchiectasi
permit
earli
treatment
ebv
infect
seriou
complic
activ
diseas
hsct
pretranspl
organ
damag
use
mismatch
donor
reduc
posthsct
surviv
almost
improv
outcom
associ
haploident
hsct
primari
immunodefici
preemptiv
earli
hsct
could
consid
patient
xlp
stabil
initi
present
even
fulli
hlamatch
donor
avail
author
contribut
zn
nr
equal
contribut
write
manuscript
conflict
interest
author
declar
conflict
interest
j
clin
immunol
fig
brain
imag
brain
mri
time
diagnosi
cn
hlh
multifoc
enhanc
lesion
involv
white
matter
area
cortic
deep
gray
matter
leptomening
enhanc
also
note
b
brain
mri
posthlh
protocol
therapi
multipl
brain
lesion
appear
extens
keep
diseas
progress
